• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

cranberry constituents modulate cytokine expression.

Snowy Owl

Retired in 2010, In Memoriam
Anti-inflammatory Activity of a High-molecular-weight Cranberry Fraction on Macrophages Stimulated by Lipopolysaccharides from Periodontopathogens

C. Bodet<SUP></SUP>, <NOBR>F. Chandad<SUP></SUP></NOBR>, and <NOBR>D. Grenier<SUP></SUP><SUP>*</SUP></NOBR>


[SIZE=-1]Groupe de Recherche en ?cologie Buccale, Facult? de M?decine Dentaire, Universit? Laval, Qu?bec City, Qu?bec, Canada G1K 7P4 [/SIZE]

http://jdr.iadrjournals.org/cgi/content/full/85/3/235
ABSTRACT
<TABLE cellPadding=5 align=right border=1><TBODY><TR><TH align=left>[SIZE=-1]TOP
dot.gif
ABSTRACT
INTRODUCTION
MATERIALS & METHODS
RESULTS
DISCUSSION
REFERENCES
[/SIZE]</TH></TR></TBODY></TABLE>

Periodontitis is a chronic inflammatory disease affecting oral<SUP> </SUP>tissues. The continuous, high production of cytokines by host<SUP> </SUP>cells triggered by periodontopathogens is thought to be responsible<SUP> </SUP>for the destruction of tooth-supporting tissues. Macrophages<SUP> </SUP>play a critical role in this host inflammatory response to periodontopathogens.<SUP> </SUP>

The aim of this study was to investigate the effect of non-dialyzable<SUP> </SUP>material prepared from cranberry juice concentrate on the pro-inflammatory<SUP> </SUP>cytokine response of macrophages induced by lipopolysaccharides<SUP> </SUP>(LPS) from Actinobacillus actinomycetemcomitans, Fusobacterium<SUP> </SUP>nucleatum subsp. nucleatum, Porphyromonas gingivalis, Treponema<SUP> </SUP>denticola, Tannerella forsythia, and Escherichia coli.

Interleukin-1<SUP> </SUP>beta (IL-1?), IL-6, IL-8, tumor necrosis factor alpha<SUP> </SUP>(TNF-
agr.gif
), and Regulated on Activation Normal T-cell Expressed<SUP> </SUP>and Secreted (RANTES) production by macrophages treated with<SUP> </SUP>the cranberry fraction prior to stimulation by LPS was evaluated<SUP> </SUP>by ELISA.

Our results clearly indicate that the cranberry fraction<SUP> </SUP>was a potent inhibitor of the pro-inflammatory cytokine and<SUP> </SUP>chemokine responses induced by LPS.

This suggests that cranberry<SUP> </SUP>constituents may offer perspectives for the development of a<SUP> </SUP>new therapeutic approach to the prevention and treatment of<SUP> </SUP>periodontitis.<SUP> </SUP>
<SUP></SUP>​

[FONT=helvetica, arial][SIZE=-2]KEY WORDS:[/SIZE]
cranberry ? periodontopathogen ? macrophage ? anti-inflammatory ? cytokine
<!-- null -->

<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#e1e1e1><TBODY><TR><TD vAlign=center align=left width="5%" bgColor=#ffffff>
rarrow.gif
</TD><TH vAlign=center align=left width="95%">[FONT=helvetica, arial][SIZE=+2] INTRODUCTION [/SIZE][/FONT]</TH></TR></TBODY></TABLE>
<TABLE cellPadding=5 align=right border=1><TBODY><TR><TH align=left>[SIZE=-1]TOP
ABSTRACT
dot.gif
INTRODUCTION
MATERIALS & METHODS
RESULTS
DISCUSSION
REFERENCES
[/SIZE]</TH></TR></TBODY></TABLE>

Periodontal diseases are a group of inflammatory disorders that<SUP> </SUP>lead to the destruction of tooth-supporting tissues and are<SUP> </SUP>caused by a specific group of Gram-negative anaerobic bacteria,<SUP> </SUP>including Porphyromonas gingivalis, Treponema denticola, and<SUP> </SUP>Tannerella forsythia (Haffajee and Socransky, 1994).

The host<SUP> </SUP>response to these bacteria and their products is a critical<SUP> </SUP>determinant in the initiation and progression of periodontitis.<SUP> </SUP>

More specifically, lipopolysaccharides (LPS) of Gram-negative<SUP> </SUP>bacteria are potent inducers of pro-inflammatory mediators and<SUP> </SUP>can initiate numerous host-mediated destructive processes (Henderson et al., 1996).<SUP> </SUP>Monocytes and macrophages, which are found in<SUP> </SUP>higher numbers in active periodontal lesions than in inactive<SUP> </SUP>sites (Zappa et al., 1991), play an important role in the host<SUP> </SUP>inflammatory response to periodontopathogens (Kornman et al.,<SUP> </SUP>1997).

The continuous, high secretion of various cytokines?including<SUP> </SUP>interleukin-1? (IL-1?), IL-6, IL-8, and<SUP> </SUP>tumor necrosis factor alpha (TNF-
agr.gif
) by host cells following stimulation<SUP> </SUP>by periodontopathogens?modulates periodontal tissue destruction<SUP> </SUP>(Okada and Murakami, 1998).

Active compounds endowed with a<SUP> </SUP>capacity to modulate the host inflammatory response are now<SUP> </SUP>receiving considerable attention, since they may be potential<SUP> </SUP>new therapeutic agents for the treatment of periodontal diseases<SUP> </SUP>(Paquette and Williams, 2000).<SUP> </SUP>


The cranberry is a native North American fruit with various<SUP> </SUP>beneficial properties for human health, such as the inhibition<SUP> </SUP>of human cancer cell line proliferation (Ferguson et al., 2004;<SUP> </SUP>Seeram et al., 2004) and the prevention of adherence of urinary<SUP> </SUP>tract infectious agents (Raz et al., 2004).

In the area of dental<SUP> </SUP>research, it has been reported that a high-molecular-weight<SUP> </SUP>fraction prepared from cranberry juice inhibits the co-aggregation<SUP> </SUP>of many oral bacteria (Weiss et al., 1998) and affects dental<SUP> </SUP>biofilm formation (Steinberg et al., 2004; Yamanaka et al.,<SUP> </SUP>2004).

In addition, this cranberry fraction reduces mutans streptococci<SUP> </SUP>levels in saliva, inhibits in vitro adhesion of Streptococcus<SUP> </SUP>sobrinus to hydroxyapatite (Weiss et al., 2004), and promotes<SUP> </SUP>S. sobrinus desorption from artificial biofilms (Steinberg et<SUP> </SUP>al., 2005).<SUP> </SUP>
<SUP></SUP>
In this study, we hypothesized that the cranberry may have a<SUP> </SUP>beneficial effect in periodontitis by exerting an anti-inflammatory<SUP> </SUP>effect.

Therefore, we investigated the effect of a high-molecular-weight<SUP> </SUP>cranberry fraction prepared from juice concentrate on the production<SUP> </SUP>by macrophages of pro-inflammatory cytokines and chemokines<SUP> </SUP>associated with periodontitis.
More specifically, the cytokine<SUP> </SUP>and chemokine responses of macrophages were induced by LPS prepared<SUP> </SUP>from Escherichia coli and from the major periodontopathogens:<SUP> </SUP>Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum<SUP> </SUP>subsp. nucleatum, P. gingivalis, T. denticola, and T. forsythia.<SUP> </SUP>
<!-- null -->

<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#e1e1e1><TBODY><TR><TD vAlign=center align=left width="5%" bgColor=#ffffff>
rarrow.gif
</TD><TH vAlign=center align=left width="95%">[FONT=helvetica, arial][SIZE=+2] MATERIALS & METHODS [/SIZE][/FONT]</TH></TR></TBODY></TABLE>
<TABLE cellPadding=5 align=right border=1><TBODY><TR><TH align=left>[SIZE=-1]TOP
ABSTRACT
INTRODUCTION
dot.gif
MATERIALS & METHODS
RESULTS
DISCUSSION
REFERENCES
[/SIZE]</TH></TR></TBODY></TABLE>

[FONT=helvetica, arial]Cranberry Fraction[/FONT]

Concentrated juice from the American cranberry Vaccinium macrocarpon<SUP> </SUP>was kindly provided by Ocean Spray Cranberries, Inc. (Lakeville-Middleboro,<SUP> </SUP>MA, USA).

The juice was exhaustively dialyzed (5 days) in 14,000<SUP> </SUP>MW cut-off dialysis bags at 4?C against distilled water<SUP> </SUP>and then lyophilized. The non-dialyzable material was considered<SUP> </SUP>as fraction 1. Undialyzed concentrated juice was also lyophilized<SUP> </SUP>and represented fraction 2. The cranberry powders were dissolved<SUP> </SUP>in distilled water prior to use. Chemical analyses of fraction<SUP> </SUP>1 were realized by Robin Roderick (Ocean Spray Cranberries,<SUP> </SUP>Inc.) and revealed that this fraction is devoid of sugars and<SUP> </SUP>acids and contains 0.35% of anthocyanins (0.055% of cyanidin-3-galactoside,<SUP> </SUP>0.003% of cyanidin-3-glucoside, 0.069% of cyanidin-3-arabinoside,<SUP> </SUP>0.116% of peonidin-3-galactoside, 0.016% of peonidin-3-glucoside,<SUP> </SUP>and 0.086% of peonidin-3-arabinoside) and 65.1% of proanthocyanidins.<SUP> </SUP>In addition, commercial epigallocatechin gallate (EGCG; Sigma<SUP> </SUP>Chemical Co., St. Louis, MO, USA), a polyphenol isolated from<SUP> </SUP>green tea, was used as a positive control (Yang et al., 1998).<SUP> </SUP>
<SUP></SUP>
[FONT=helvetica, arial]LPS Preparation[/FONT]
A. actinomycetemcomitans ATCC 29522, F. nucleatum subsp. nucleatum<SUP> </SUP>ATCC 25586, P. gingivalis ATCC 33277, T. denticola ATCC 35405,<SUP> </SUP>and T. forsythia ATCC 43037 were grown in their appropriate<SUP> </SUP>culture media (Grenier, 1996). LPS were isolated from these<SUP> </SUP>bacterial strains, as previously reported (Darveau and Hancock, 1983).<SUP> </SUP>This method is based on protein digestion of a whole-cell<SUP> </SUP>extract by proteinase K and successive solubilization and precipitation<SUP> </SUP>steps.

The LPS preparations were freeze-dried and kept at ?20?C.<SUP> </SUP>The amount of contaminating protein was evaluated with the use<SUP> </SUP>of a protein assay kit (Bio-Rad Laboratories, Mississauga, ON,<SUP> </SUP>Canada), with bovine serum albumin as a control, and was less<SUP> </SUP>than 0.001% in all LPS preparations. T. denticola possesses<SUP> </SUP>a lipooligosaccharide (although it will be called LPS in the<SUP> </SUP>present paper) that has properties rather distinct from those<SUP> </SUP>of the classic LPS of the Bacteroides group (Schultz et al.,<SUP> </SUP>1998). A standard LPS preparation from E. coli O55:B5 (Sigma<SUP> </SUP>Chemical Co.) was also used.<SUP> </SUP>
[FONT=helvetica, arial][/FONT]
[FONT=helvetica, arial]Monocyte and Macrophage Cultures[/FONT]

U937 cells (ATCC CRL-1593.2), a monoblastic leukemia cell line,<SUP> </SUP>were cultivated at 37?C in a 5% CO<SUB>2</SUB> atmosphere in RPMI-1640<SUP> </SUP>medium (HyClone Laboratories, Logan, UT, USA) supplemented with<SUP> </SUP>10% heat-inactivated fetal bovine serum (FBS) (RPMI-FBS) and<SUP> </SUP>100 ?g/mL of penicillin-streptomycin. Monocytes (2 x 10<SUP>5</SUP><SUP> </SUP>cells/mL) were incubated in RPMI-FBS containing 10 ng/mL of<SUP> </SUP>phorbol myristic acid (PMA; Sigma) for 48 hrs to induce differentiation<SUP> </SUP>into adherent macrophage-like cells, as previously reported<SUP> </SUP>(Rovera et al., 1979).

Following the PMA treatment, the medium<SUP> </SUP>was replaced with fresh medium, and the differentiated cells<SUP> </SUP>were incubated for an additional 24 hrs prior to use. Adherent<SUP> </SUP>macrophages were suspended in RPMI-FBS and centrifuged at 200<SUP> </SUP>x g for 8 min. They were washed and suspended in RPMI with 1%<SUP> </SUP>heat-inactivated FBS at a density of 1 x 10<SUP>6</SUP> cells/mL and seeded<SUP> </SUP>in a six-well plate (2 x 10<SUP>6</SUP> cells/well in 2 mL) at 37?C<SUP> </SUP>in a 5% CO<SUB>2</SUB> atmosphere.<SUP> </SUP>
[FONT=helvetica, arial][/FONT]
[FONT=helvetica, arial]Treatment of Macrophages[/FONT]

The macrophages were treated with increasing concentrations<SUP> </SUP>of fraction 1, fraction 2, and EGCG, ranging from 10 to 50 ?g/mL,<SUP> </SUP>and incubated at 37?C in 5% CO<SUB>2</SUB> for 2 hrs before stimulation<SUP> </SUP>with LPS at a final concentration of 1 ?g/mL. After a<SUP> </SUP>24-hour incubation (37?C in 5% CO<SUB>2</SUB>), the culture medium<SUP> </SUP>supernatants were collected and stored at ?20?C until<SUP> </SUP>used. Cells incubated in culture medium with or without cranberry<SUP> </SUP>fraction or EGCG, but not stimulated with LPS, were used as<SUP> </SUP>controls.<SUP> </SUP>
<SUP></SUP>
[FONT=helvetica, arial]Cell Viability[/FONT]

Macrophage viability was evaluated by 0.2% Trypan Blue staining.<SUP> </SUP>Cell viability of macrophages was also evaluated by a MTT (3-[4,5-diethylthiazol-2-yl]-2,5-diphenyltetrazolium<SUP> </SUP>bromide) test, according to the manufacturer?s protocol<SUP> </SUP>(Roche Diagnostics, Mannheim, Germany).<SUP> </SUP>
<SUP></SUP>
[FONT=helvetica, arial]Determination of Cytokine Production[/FONT]

We used commercial enzyme-linked immunosorbent assay (ELISA)<SUP> </SUP>kits (R&D Systems, Minneapolis, MN, USA) to quantify IL-1?,<SUP> </SUP>IL-6, IL-8, TNF-
agr.gif
, and RANTES concentrations in the cell-free<SUP> </SUP>culture supernatants, according to the manufacturer?s<SUP> </SUP>protocols. The absorbance at 450 nm was read in a microplate<SUP> </SUP>reader with the wavelength correction set at 550 nm.<SUP> </SUP>
[FONT=helvetica, arial][/FONT]
[FONT=helvetica, arial]Statistical Analyses[/FONT]

We performed two-way analyses of variance to compare the means<SUP> </SUP>of the different conditions. Differences were deemed significant<SUP> </SUP>at the 0.05 level (P value). Protected Fisher least-significant<SUP> </SUP>differences were used for pairwise comparisons.<SUP> </SUP>
<!-- null -->

<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#e1e1e1><TBODY><TR><TD vAlign=center align=left width="5%" bgColor=#ffffff>
rarrow.gif
</TD><TH vAlign=center align=left width="95%">[FONT=helvetica, arial][SIZE=+2] RESULTS [/SIZE][/FONT]</TH></TR></TBODY></TABLE>
<TABLE cellPadding=5 align=right border=1><TBODY><TR><TH align=left>[SIZE=-1]TOP
ABSTRACT
INTRODUCTION
MATERIALS & METHODS
dot.gif
RESULTS
DISCUSSION
REFERENCES
[/SIZE]</TH></TR></TBODY></TABLE>

[FONT=helvetica, arial]Effects of Cranberry Fractions on LPS-induced Pro-inflammatory Cytokine Production[/FONT]

To investigate the effects of cranberry fractions on pro-inflammatory<SUP> </SUP>cytokine production, we treated macrophages with lyophilized<SUP> </SUP>non-dialyzable material of cranberry juice concentrate (fraction<SUP> </SUP>1) or lyophilized cranberry juice concentrate (fraction 2) prior<SUP> </SUP>to stimulation with the LPS of major periodontopathogens.

To<SUP> </SUP>exclude the possibility that cell toxicity due to the cranberry<SUP> </SUP>fractions might have been responsible for a decrease in cytokine<SUP> </SUP>levels, we evaluated the viability of the macrophages by an<SUP> </SUP>MTT test and Trypan blue exclusion.

No obvious cytotoxic effects<SUP> </SUP>were detected following treatments of macrophages with both<SUP> </SUP>fractions, and cell viability was
ge.gif
94% of the untreated controls<SUP> </SUP>in all experiments (data not shown).<SUP> </SUP>
<SUP></SUP>
For IL-1?, TNF-
agr.gif
, and IL-6, the interaction between<SUP> </SUP>the two factors LPS and cranberry was significant (P < 0.05),<SUP> </SUP>and the results of pairwise comparisons were used. The TNF-
agr.gif
<SUP> </SUP>and IL-6 responses of the macrophages stimulated by LPS from<SUP> </SUP>A. actinomycetemcomitans were significantly reduced by the treatments<SUP> </SUP>with fraction 1 (25 and 50 ?g/mL) and EGCG (10 ?g/mL)<SUP> </SUP>(Figs. 1A, 1B).

This effect was not observed when the macrophages<SUP> </SUP>were treated with fraction 2. Among the other LPS tested, the<SUP> </SUP>LPS from F. nucleatum subsp. nucleatum and E. coli induced a<SUP> </SUP>TNF-
agr.gif
response, whereas an IL-6 response was induced only by<SUP> </SUP>the LPS of F. nucleatum subsp. nucleatum (Table). Fraction 1<SUP> </SUP>at a final concentration of 50 ?g/mL inhibited the TNF-
agr.gif
<SUP> </SUP>and IL-6 responses of macrophages induced by the LPS of F. nucleatum<SUP> </SUP>subsp. nucleatum, as well as the TNF-
agr.gif
response induced by the<SUP> </SUP>LPS of E. coli.<SUP> </SUP>

<!-- null -->
<CENTER><TABLE cellSpacing=0 cellPadding=0 width="95%"><TBODY><TR bgColor=#e1e1e1><TD><TABLE cellSpacing=2 cellPadding=2><TBODY><TR bgColor=#e1e1e1><TD vAlign=top align=middle bgColor=#ffffff>
View larger version (20K):
<NOBR>[in this window]
[in a new window]
</NOBR> </TD><TD vAlign=top align=left>Figure 1. Effect of treating macrophages with fraction 1 (non-dialyzable material of cranberry juice), fraction 2 (cranberry juice), and epigallocatechin gallate (EGCG) on the secretion of IL-6 (A), TNF-
agr.gif
(B), and IL-1? (C) induced by LPS (1 ?g/mL) of A. actinomycetemcomitans ATCC 29522 for 24 hrs. Macrophages were treated with cranberry fractions, or EGCG, for 2 hrs prior to lipopolysaccharides (LPS) stimulation. Cytokine secretion was assessed by ELISA. The data are the means ? standard deviations of triplicate assays for three independent experiments. *P value of < 0.05 compared with untreated control.
</TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>

<!-- null -->
<CENTER><TABLE cellSpacing=0 cellPadding=0 width="95%"><TBODY><TR bgColor=#e1e1e1><TD><TABLE cellSpacing=2 cellPadding=2><TBODY><TR bgColor=#e1e1e1><TD vAlign=top align=middle bgColor=#ffffff>View this table:
<NOBR>[in this window]
[in a new window]
</NOBR> </TD><TD vAlign=top align=left>Table. Effect of the Cranberry Non-dialyzable Material (fraction 1) on the Secretion by Macrophages<SUP>a</SUP> of IL-1?, TNF-
agr.gif
, IL-6, IL-8, and RANTES Induced by LPS (1 ?g/mL) of F. nucleatum subsp. nucleatum ATCC 25586, P. gingivalis ATCC 33277, T. denticola ATCC 35405, T. forsythia ATCC 43037, and E. coli O55:B5 for 24 hrs </TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>

Antagonist effects of fraction 1 on A. actinomycetemcomitans<SUP> </SUP>LPS-induced IL-1? release were observed (Fig. 1C).<SUP> </SUP>At low concentrations (10 and 25 ?g/mL), fraction 1 and<SUP> </SUP>the LPS of A. actinomycetemcomitans showed a synergistic effect<SUP> </SUP>on IL-1? production.

However, at a concentration of<SUP> </SUP>50 ?g/mL, fraction 1 caused a significant reduction in<SUP> </SUP>LPS-induced IL-1? secretion by macrophages that was<SUP> </SUP>comparable with that obtained with EGCG. This concentration-dependent<SUP> </SUP>effect on IL-1? production was also observed when<SUP> </SUP>macrophages were stimulated with the LPS of F. nucleatum subsp.<SUP> </SUP>nucleatum (Table). The treatment of macrophages with 10 ?g/mL<SUP> </SUP>fraction 1 induced an increase of F. nucleatum subsp. nucleatum<SUP> </SUP>LPS-stimulated IL-1? secretion, whereas the treatment<SUP> </SUP>with a higher concentration (50 ?g/mL) significantly reduced<SUP> </SUP>the amount of IL-1? secreted. Treatment of the macrophages<SUP> </SUP>with fraction 1 (10 and 50 ?g/mL) without LPS stimulation<SUP> </SUP>had no effect on the basal level of IL-1? (data not<SUP> </SUP>shown).

Only a weak IL-1? secretion was observed following<SUP> </SUP>stimulations of macrophages with the LPS of P. gingivalis, T.<SUP> </SUP>denticola, or T. forsythia, and fraction 1 showed no significant<SUP> </SUP>effect (Table).<SUP> </SUP>
<SUP></SUP>​
[FONT=helvetica, arial]Effects of Cranberry Fractions on LPS-induced Chemokine Production[/FONT]

For IL-8, the interaction between LPS and the cranberry fractions<SUP> </SUP>was not significant, and the effects of cranberry fraction 1<SUP> </SUP>were analyzed without discrimination of LPS source. LPS of A.<SUP> </SUP>actinomycetemcomitans induced a higher IL-8 response than did<SUP> </SUP>the other LPS tested (P < 0.05). Fraction 1 (50 ?g/mL)<SUP> </SUP>significantly reduced the IL-8 response of macrophages stimulated<SUP> </SUP>with LPS (Fig. 2A, Table). Fraction 2 and EGCG had no effect<SUP> </SUP>on IL-8 production by LPS-stimulated macrophages.<SUP> </SUP>

<!-- null -->
<CENTER><TABLE cellSpacing=0 cellPadding=0 width="95%"><TBODY><TR bgColor=#e1e1e1><TD><TABLE cellSpacing=2 cellPadding=2><TBODY><TR bgColor=#e1e1e1><TD vAlign=top align=middle bgColor=#ffffff>
View larger version (25K):
<NOBR>[in this window]
[in a new window]
</NOBR> </TD><TD vAlign=top align=left>Figure 2. Effect of treating macrophages with fraction 1 (non-dialyzable material of cranberry juice), fraction 2 (cranberry juice), and epigallocatechin gallate (EGCG) on the secretion of IL-8 (A) and RANTES (B) induced by LPS (1 ?g/mL) of A. actinomycetemcomitans ATCC 29522 for 24 hrs. Macrophages were treated with cranberry fractions, or EGCG, for 2 hrs before lipopolysaccharides (LPS) stimulation. Cytokine secretion was assessed by ELISA. The data are the means ? standard deviations of triplicate assays for three independent experiments. *P value of < 0.05 compared with untreated control.
</TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>

For RANTES, the interaction between LPS and the cranberry fractions<SUP> </SUP>was significant, and the results of pairwise comparisons were<SUP> </SUP>used. Fraction 1 and EGCG significantly reduced the RANTES response<SUP> </SUP>induced by the LPS of A. actinomycetemcomitans at all the concentrations<SUP> </SUP>tested (Fig. 2B). Fraction 1 also inhibited the RANTES response<SUP> </SUP>induced by the LPS of F. nucleatum, P. gingivalis, T. forsythia,<SUP> </SUP>and E. coli at all the concentrations tested (Table). A concentration<SUP> </SUP>of 50 ?g/mL of fraction 1 was necessary to cause a significant<SUP> </SUP>decrease in the RANTES response induced by the LPS of T. denticola<SUP> </SUP>(Table).<SUP> </SUP>​
<!-- null -->

<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#e1e1e1><TBODY><TR><TD vAlign=center align=left width="5%" bgColor=#ffffff>
rarrow.gif
</TD><TH vAlign=center align=left width="95%">[FONT=helvetica, arial][SIZE=+2] DISCUSSION [/SIZE][/FONT]</TH></TR></TBODY></TABLE>
<TABLE cellPadding=5 align=right border=1><TBODY><TR><TH align=left>[SIZE=-1]TOP
ABSTRACT
INTRODUCTION
MATERIALS & METHODS
RESULTS
dot.gif
DISCUSSION
REFERENCES
[/SIZE]</TH></TR></TBODY></TABLE>

The host inflammatory response to periodontopathogens is considered<SUP> </SUP>a major factor causing the local tissue destruction observed<SUP> </SUP>in periodontitis.

Macrophages participate in the host response<SUP> </SUP>induced by periodontopathogens and are the principal target<SUP> </SUP>for LPS.

To determine whether cranberry extracts can interfere<SUP> </SUP>with LPS signaling and reduce the production of pro-inflammatory<SUP> </SUP>molecules, we stimulated cranberry-fraction-treated macrophages<SUP> </SUP>with the LPS from major periodontopathogens and from E. coli.<SUP> </SUP>

The cranberry non-dialyzable material significantly reduced<SUP> </SUP>LPS-induced pro-inflammatory cytokine and chemokine production.<SUP> </SUP>
<SUP></SUP>
Cytokines, more particularly IL-1?, are potential<SUP> </SUP>markers of the progression and severity of periodontitis as<SUP> </SUP>well as indicators of an appropriate response to treatment (Hou et al., 1995).<SUP> </SUP>

It has been reported that cytokine synthesis<SUP> </SUP>inhibitors can reduce bone resorption in experimental periodontitis<SUP> </SUP>in rats (Lima et al., 2004).

Moreover, local inhibition of both<SUP> </SUP>IL-1 and TNF production in periodontal tissues significantly<SUP> </SUP>inhibits the inflammatory response and bone loss in ligature-induced<SUP> </SUP>periodontitis in monkeys (Assuma et al., 1998).

This suggests<SUP> </SUP>that local inhibition of cytokines may be a successful approach<SUP> </SUP>for inhibiting bone resorption in periodontitis.

In this study,<SUP> </SUP>we showed that treating macrophages with the non-dialyzable<SUP> </SUP>material of cranberry juice can inhibit LPS-induced IL-1?,<SUP> </SUP>TNF-
agr.gif
, and IL-6 production and may thus contribute to reducing<SUP> </SUP>the impact of cytokine-mediated host destructive processes in<SUP> </SUP>periodontitis.<SUP> </SUP>
<SUP></SUP>

IL-8 and RANTES are potent chemokines that direct the migration<SUP> </SUP>of neutrophils, eosinophils, monocytes, and T<SUB>H</SUB>1 cells to sites<SUP> </SUP>of infection (Luster, 1998).

Stimulation of chemokine production<SUP> </SUP>by periodontopathogens favors the accumulation of leukocytes<SUP> </SUP>during active inflammation, which contributes to periodontal<SUP> </SUP>tissue destruction.

Interestingly, periodontal therapy reduces<SUP> </SUP>cell numbers in the infiltrate and the levels of IL-8 and RANTES,<SUP> </SUP>suggesting a relationship between these chemokines and periodontal<SUP> </SUP>status (Gamonal et al., 2001).

The non-dialyzable material of<SUP> </SUP>cranberry juice reduced LPS-induced IL-8 and RANTES production<SUP> </SUP>by macrophages.

In the context of the development of novel therapeutic<SUP> </SUP>strategies targeting the control of periodontal inflammatory<SUP> </SUP>reactions, these results suggest that this cranberry fraction<SUP> </SUP>may help reduce the influx of inflammatory cells at disease<SUP> </SUP>sites.<SUP> </SUP>
<SUP></SUP> The lyophilized cranberry juice did not show any capacity to<SUP> </SUP>inhibit LPS-induced cytokine production by macrophages.

This<SUP> </SUP>is likely related to the fact that active compounds were concentrated<SUP> </SUP>in the non-dialyzable material of cranberry juice.

One such<SUP> </SUP>group of compounds that showed a 125-fold enrichment was the<SUP> </SUP>proanthocyanidins (data not shown). EGCG, the green tea polyphenol<SUP> </SUP>used as a positive control, also showed anti-inflammatory activity.<SUP> </SUP>This is in agreement with the previously reported capacity of<SUP> </SUP>EGCG to inhibit LPS-induced TNF-
agr.gif
production by mouse macrophages<SUP> </SUP>(Yang et al., 1998).

Previous studies have revealed that some<SUP> </SUP>plant flavonoids may inhibit the expression of inflammation-related<SUP> </SUP>proteins/enzymes by suppressing activation of transcription<SUP> </SUP>factors such as nuclear transcription factor-
kappa.gif
B and activator<SUP> </SUP>protein-1 (
Kim et al., 2004).

Future studies will investigate<SUP> </SUP>the cellular mechanisms by which cranberry constituents modulate<SUP> </SUP>cytokine expression.<SUP> </SUP>
<SUP></SUP>

Therapeutic agents that modulate host inflammatory mediators<SUP> </SUP>have shown promise for managing adult periodontitis and may<SUP> </SUP>be highly useful for individuals with a substantially increased<SUP> </SUP>risk for periodontitis (Kornman, 1999).

In addition to the previously<SUP> </SUP>recognized inhibitory effect of the cranberry non-dialyzable<SUP> </SUP>material fraction on the aggregation of oral bacteria and dental<SUP> </SUP>biofilm formation (Weiss et al., 1998; Steinberg et al., 2004),<SUP> </SUP>we showed that this fraction was a potent inhibitor of the pro-inflammatory<SUP> </SUP>cytokine and chemokine responses induced by periodontopathogens<SUP> </SUP>and E. coli.

This provides promising perspectives for the development<SUP> </SUP>of novel host-modulating therapies for adjunctive treatments<SUP> </SUP>of periodontitis or other inflammatory diseases by use of the<SUP> </SUP>high-molecular-weight constituents from cranberries.<SUP> </SUP><SUP></SUP>
<!-- null -->

<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#e1e1e1><TBODY><TR><TD vAlign=center align=left width="5%" bgColor=#ffffff>
rarrow.gif
</TD><TH vAlign=center align=left width="95%">[FONT=helvetica, arial][SIZE=+2] ACKNOWLEDGMENTS [/SIZE][/FONT]</TH></TR></TBODY></TABLE>

This work was supported by the Cranberry Institute (East Wareham,<SUP> </SUP>MA, USA). We thank Robin Roderick and Marge Leahy (Ocean Spray<SUP> </SUP>Cranberries, Inc.) for chemical analyses and for providing cranberry<SUP> </SUP>juice concentrate.<SUP> </SUP>
<SUP></SUP>

Received April 25, 2005; Last revision October 14, 2005; Accepted October 26, 2005
<!-- null -->
<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#e1e1e1><TBODY><TR><TD vAlign=center align=left width="5%" bgColor=#ffffff>
rarrow.gif
</TD><TH vAlign=center align=left width="95%">[FONT=helvetica, arial][SIZE=+2] REFERENCES [/SIZE][/FONT]</TH></TR></TBODY></TABLE><TABLE cellPadding=5 align=right border=1><TBODY><TR><TH align=left>[SIZE=-1]TOP
ABSTRACT
INTRODUCTION
MATERIALS & METHODS
RESULTS
DISCUSSION
dot.gif
REFERENCES
[/SIZE]</TH></TR></TBODY></TABLE>
<!-- null -->Assuma R, Oates T, Cochran D, Amar S, Graves DT (1998). IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 160:403?409.<!-- HIGHWIRE ID="85:3:235:1" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Darveau RP, Hancock RE (1983). Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 155:831?838.<!-- HIGHWIRE ID="85:3:235:2" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ (2004). A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134:1529?1535.<!-- HIGHWIRE ID="85:3:235:3" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2001).

Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36:194?203.<!-- HIGHWIRE ID="85:3:235:4" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Grenier D (1996).

Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola. Microbiology 142(Pt 4):955?961.<!-- HIGHWIRE ID="85:3:235:5" -->[Abstract]<!-- /HIGHWIRE -->
<!-- null -->Haffajee AD, Socransky SS (1994). Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 5:78?111.<!-- HIGHWIRE ID="85:3:235:6" --><!-- /HIGHWIRE -->
<!-- null -->Henderson B, Poole S, Wilson M (1996). Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60:316?341.<!-- HIGHWIRE ID="85:3:235:7" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Hou LT, Liu CM, Rossomando EF (1995). Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 22:162?167.<!-- HIGHWIRE ID="85:3:235:8" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Kim HP, Son KH, Chang HW, Kang SS (2004). Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96:229?245.<!-- HIGHWIRE ID="85:3:235:9" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Kornman KS (1999). Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 28:520?526.<!-- HIGHWIRE ID="85:3:235:10" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Kornman KS, Page RC, Tonetti MS (1997). The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14:33?53.<!-- HIGHWIRE ID="85:3:235:11" --><!-- /HIGHWIRE -->
<!-- null -->Lima V, Vidal FD, Rocha FA, Brito GA, Ribeiro RA (2004). Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. J Periodontol 75:162?168.<!-- HIGHWIRE ID="85:3:235:12" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Luster AD (1998). Chemokines?chemotactic cytokines that mediate inflammation. N Engl J Med 338:436?445.<!-- HIGHWIRE ID="85:3:235:13" --><NOBR>[Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Okada H, Murakami S (1998). Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9:248?266.<!-- HIGHWIRE ID="85:3:235:14" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Paquette DW, Williams RC (2000). Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 24:239?252.<!-- HIGHWIRE ID="85:3:235:15" --><!-- /HIGHWIRE -->
<!-- null -->Raz R, Chazan B, Dan M (2004). Cranberry juice and urinary tract infection. Clin Infect Dis 38:1413?1419.<!-- HIGHWIRE ID="85:3:235:16" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Rovera G, Santoli D, Damsky C (1979). Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 76:2779?2783.<!-- HIGHWIRE ID="85:3:235:17" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Schultz CP, Wolf V, Lange R, Mertens E, Wecke J, Naumann D, et al. (1998). Evidence for a new type of outer membrane lipid in oral spirochete Treponema denticola. Functioning permeation barrier without lipopolysaccharides. J Biol Chem 273:15661?15666.<!-- HIGHWIRE ID="85:3:235:18" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Seeram NP, Adams LS, Hardy ML, Heber D (2004). Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem 52:2512?2517.<!-- HIGHWIRE ID="85:3:235:19" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Steinberg D, Feldman M, Ofek I, Weiss EI (2004). Effect of a high-molecular-weight component of cranberry on constituents of dental biofilm. J Antimicrob Chemother 54:86?89.<!-- HIGHWIRE ID="85:3:235:20" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Steinberg D, Feldman M, Ofek I, Weiss EI (2005). Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. Int J Antimicrob Agents 25:247?251.<!-- HIGHWIRE ID="85:3:235:21" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Weiss EI, Lev-Dor R, Kashamn Y, Goldhar J, Sharon N, Ofek I (1998). Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent. J Am Dent Assoc 129:1719?1723. [Published erratum appears in J Am Dent Assoc 130(1):36 and 130(3):332, 1999.]<!-- HIGHWIRE ID="85:3:235:22" -->[Abstract]<!-- /HIGHWIRE -->
<!-- null -->Weiss EI, Kozlovsky A, Steinberg D, Lev-Dor R, Bar Ness Greenstein R, Feldman M, et al. (2004). A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite. FEMS Microbiol Lett 232:89?92.<!-- HIGHWIRE ID="85:3:235:23" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Yamanaka A, Kimizuka R, Kato T, Okuda K (2004). Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 19:150?154.<!-- HIGHWIRE ID="85:3:235:24" -->[ISI][Medline]<!-- /HIGHWIRE -->
<!-- null -->Yang F, de Villiers WJ, McClain CJ, Varilek GW (1998). Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 128:2334?2340.<!-- HIGHWIRE ID="85:3:235:25" --><NOBR>[Abstract/Free Full Text]</NOBR><!-- /HIGHWIRE -->
<!-- null -->Zappa U, Reinking-Zappa M, Graf H, Espeland M (1991). Cell populations and episodic periodontal attachment loss in humans. J Clin Periodontol 18:508?515.<!-- HIGHWIRE ID="85:3:235:26" -->[ISI][Medline]<!-- /HIGHWIRE -->



<!-- null -->
[SIZE=+2]This article has been cited by other articles:[/SIZE] <TABLE cellSpacing=0 cellPadding=0 width=600 border=0><TBODY><TR bgColor=#d9d4c5><TD vAlign=top align=middle width=25>
spacer.gif

</TD><TD width=5>
spacer.gif
</TD><TD vAlign=top noWrap align=middle width=61>
</TD><TD width=5>
spacer.gif
</TD><TD vAlign=top noWrap width=499>
[FONT=verdana,arial,helvetica][SIZE=-1]C. C. Neto
Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies
J. Nutr., January 1, 2007; 137(1): 186S - 193S.
[Abstract] [Full Text] [PDF]
spacer.gif
[/SIZE][/FONT]</TD><TD width=5>
spacer.gif
</TD></TR><TR><TD colSpan=6><HR align=left width=600 color=#828282 noShade SIZE=1></TD></TR></TBODY></TABLE><TABLE cellSpacing=0 cellPadding=0 width=600 border=0><TBODY><TR bgColor=#d9d4c5><TD vAlign=top align=middle width=25>
spacer.gif

</TD><TD width=5>
spacer.gif
</TD><TD vAlign=top noWrap align=middle width=61>
</TD><TD width=5>
spacer.gif
</TD><TD vAlign=top noWrap width=499>
[FONT=verdana,arial,helvetica][SIZE=-1]J. Labrecque, C. Bodet, F. Chandad, and D. Grenier
Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis
J. Antimicrob. Chemother., August 1, 2006; 58(2): 439 - 443.
[Abstract] [Full Text] [PDF]
spacer.gif
[/SIZE][/FONT]</TD><TD width=5>
spacer.gif
</TD></TR><TR><TD colSpan=6><HR align=left width=600 color=#828282 noShade SIZE=1></TD></TR></TBODY></TABLE><TABLE cellSpacing=0 cellPadding=0 width=600 border=0><TBODY><TR bgColor=#d9d4c5><TD vAlign=top align=middle width=25>
spacer.gif

</TD><TD width=5>
spacer.gif
</TD><TD vAlign=top noWrap align=middle width=61>
</TD><TD width=5>
spacer.gif
</TD><TD vAlign=top noWrap width=499>
[FONT=verdana,arial,helvetica][SIZE=-1]C. Bodet, M. Piche, F. Chandad, and D. Grenier
Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry
J. Antimicrob. Chemother., April 1, 2006; 57(4): 685 - 690.
[Abstract] [Full Text] [PDF]
spacer.gif
[/SIZE][/FONT]</TD><TD width=5>
spacer.gif
</TD></TR><TR><TD colSpan=6><HR align=left width=600 color=#828282 noShade SIZE=1></TD></TR></TBODY></TABLE>
<TABLE class=content_box_outer_table align=right><TBODY><TR><TD><!-- beginning of inner table --><TABLE class=content_box_inner_table><!-- citation --><TBODY><TR><TD class=content_box_title_highlight colSpan=2>This Article</TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Abstract
free.gif
</TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Figures Only </TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_title colSpan=2>Services</TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Similar articles in this journal </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Similar articles in ISI Web of Science</STRONG> </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Similar articles in PubMed </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Alert me to new issues of the journal </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Download to citation manager </TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_title colSpan=2>Citing Articles</TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Citing Articles via HighWire </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Citing Articles via ISI Web of Science (10) </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Citing Articles via Google Scholar </TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_title colSpan=2>Google Scholar</TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Articles by Bodet, C. </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Articles by Grenier, D. </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Search for Related Content </TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_title colSpan=2>PubMed</TD></TR><TR><TD class=content_box_space_between_sections colSpan=2>
spacer.gif
</TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>PubMed Citation </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Articles by Bodet, C. </TD></TR><TR><TD class=content_box_arrow vAlign=top width=4>
arrowTtrim.gif
</TD><TD class=content_box_item>Articles by Grenier, D. </TD></TR></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>

[/FONT]
 
Re: cranberry constituents modulate cytokine expression.

Cranberry and Its Phytochemicals:
A Review of In Vitro Anticancer Studies<SUP>1</SUP>
http://jn.nutrition.org/cgi/content/abstract/137/1/186S
Catherine C. Neto<SUP>*</SUP>


<SUP></SUP>Department of Chemistry and Biochemistry, University of Massachusetts?Dartmouth, North Dartmouth, MA 02747
<!-- ABS -->This article reviews the existing research on the anticancer<SUP> </SUP>properties of cranberry fruit and key phytochemicals that are<SUP> </SUP>likely contributors to chemoprevention.

Results from in vitro<SUP> </SUP>studies using a variety of tumor models show that polyphenolic<SUP> </SUP>extracts from Vaccinium macrocarpon inhibit the growth and proliferation<SUP> </SUP>of breast, colon, prostate, lung, and other tumors, as do flavonols,<SUP> </SUP>proanthocyanidin oligomers, and triterpenoids isolated from<SUP> </SUP>the fruit.

The unique combination of phytochemicals found in<SUP> </SUP>cranberry fruit may produce synergistic health benefits. Possible<SUP> </SUP>chemopreventive mechanisms of action by cranberry phytochemicals<SUP> </SUP>include induction of apoptosis in tumor cells, reduced ornithine<SUP> </SUP>decarboxylase activity, decreased expression of matrix metalloproteinases<SUP> </SUP>associated with prostate tumor metastasis, and antiinflammatory<SUP> </SUP>activities including inhibition of cyclooxygenases.

These findings<SUP> </SUP>suggest a potential role for cranberry as a dietary chemopreventive<SUP> </SUP>and provide direction for future research.<SUP> </SUP>
 
Back
Top